Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response

JCO precision oncology(2023)

引用 0|浏览7
暂无评分
摘要
Analysis of 260K tumors IDs copy-number signatures and a HRD biomarker predictive of PARPi response.
更多
查看译文
关键词
homologous recombination deficiency biomarker,poly,pan-cancer,copy-number,adp-ribose
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要